Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Habegger

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Nature|October 11, 2023
Genotyping, sequencing and analysis of 140,000 adults from Mexico CityAndrey Ziyatdinov, Jason Torres, Jesús Alegre-Díaz, et al.
Nature|January 8, 2025
Author Correction: A deep catalogue of protein-coding variation in 983,578 individualsKathie Y Sun, Xiaodong Bai, Siying Chen, et al.
Nature|October 22, 2020
Exome sequencing and characterization of 49,960 individuals in the UK BiobankCristopher V Van Hout, Ioanna Tachmazidou, Joshua D Backman, et al.
Science (New York, N.Y.)|February 21, 2012
A systematic survey of loss-of-function variants in human protein-coding genesDaniel G MacArthur, Suganthi Balasubramanian, Adam Frankish, et al.
Nature Genetics|August 5, 2024
Genetic risk factors for COVID-19 and influenza are largely distinctJack A Kosmicki, Anthony Marcketta, Deepika Sharma, et al.
Science (New York, N.Y.)|December 24, 2016
Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR studyFrederick E Dewey, Michael F Murray, John D Overton, et al.
Nature Genetics|March 4, 2022
Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe diseaseJulie E Horowitz, Jack A Kosmicki, Amy Damask, et al.
The New England Journal of Medicine|May 25, 2017
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular DiseaseFrederick E Dewey, Viktoria Gusarova, Richard L Dunbar, et al.
American Journal of Human Genetics|June 11, 2021
Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individualsJack A Kosmicki, Julie E Horowitz, Nilanjana Banerjee, et al.
Nature Communications|June 15, 2018
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetesViktoria Gusarova, Colm O'Dushlaine, Tanya M Teslovich, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Nature|October 11, 2023
Genotyping, sequencing and analysis of 140,000 adults from Mexico CityAndrey Ziyatdinov, Jason Torres, Jesús Alegre-Díaz, et al.
Nature|January 8, 2025
Author Correction: A deep catalogue of protein-coding variation in 983,578 individualsKathie Y Sun, Xiaodong Bai, Siying Chen, et al.
Nature|October 22, 2020
Exome sequencing and characterization of 49,960 individuals in the UK BiobankCristopher V Van Hout, Ioanna Tachmazidou, Joshua D Backman, et al.
Science (New York, N.Y.)|February 21, 2012
A systematic survey of loss-of-function variants in human protein-coding genesDaniel G MacArthur, Suganthi Balasubramanian, Adam Frankish, et al.
Nature Genetics|August 5, 2024
Genetic risk factors for COVID-19 and influenza are largely distinctJack A Kosmicki, Anthony Marcketta, Deepika Sharma, et al.
Science (New York, N.Y.)|December 24, 2016
Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR studyFrederick E Dewey, Michael F Murray, John D Overton, et al.
Nature Genetics|March 4, 2022
Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe diseaseJulie E Horowitz, Jack A Kosmicki, Amy Damask, et al.
The New England Journal of Medicine|May 25, 2017
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular DiseaseFrederick E Dewey, Viktoria Gusarova, Richard L Dunbar, et al.
American Journal of Human Genetics|June 11, 2021
Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individualsJack A Kosmicki, Julie E Horowitz, Nilanjana Banerjee, et al.
Nature Communications|June 15, 2018
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetesViktoria Gusarova, Colm O'Dushlaine, Tanya M Teslovich, et al.
Pageof 5